Please use this identifier to cite or link to this item:
Title: Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain
Author: Fernández de Larrea Baz, Nerea
Michel, Angelika
Romero, Beatriz
Pérez Gómez, Beatriz
Moreno Aguado, Víctor
Martín Sánchez, Vicente
Dierssen Sotos, Trinidad
Jiménez Moleón, José Juan
Castilla, Jesús
Tardón, Adonina
Ruiz, Irune
Peiró Pérez, Rosana
Tejada, Antonio
Chirlaque, María Dolores
Butt, Julia A.
Olmedo Requena, Rocío
Gómez Acebo, Inés
Linares, Pedro
Boldo, Elena
Castells Garangou, Antoni
Pawlita, Michael
Castaño-Vinyals, Gemma
Kogevinas, Manolis
Sanjosé Llongueras, Silvia de
Pollán, Marina
Campo, Rosa del
Waterboer, Tim
Aragonès Sanz, Núria
Keywords: Helicobacteri pilòric
Càncer colorectal
Helicobacter pylori
Colorectal cancer
Issue Date: 29-May-2017
Publisher: Frontiers Media
Abstract: Background: Several studies have suggested that Helicobacter pylori (H. pylori) infection is a risk factor for colorectal cancer (CRC), while others have not confirmed this hypothesis. This work aimed to assess the relation of CRC with H. pylori seropositivity and with seropositivity to 16 H. pylori proteins, in the MultiCase-Control study, MCC-Spain.Methods: MCC-Spain is a multicase-control study carried out in Spain from 2008 to 2013. In total, 2,140 histologically-confirmed incident CRC cases and 4,098 population-based controls were recruited. Controls were frequency-matched by sex, age, and province. Epidemiological data were collected through a questionnaire fulfilled by face-to-face interviews and a self-administered food-frequency questionnaire. Seroreactivities against 16 H. pylori proteins were determined in 1,488 cases and 2,495 controls using H. pylori multiplex serology. H. pylori seropositivity was defined as positivity to >= 4 proteins. Multivariable logistic regression mixed models were used to estimate odds ratios (OR) and 95% confidence intervals (CI).Results: H. pylori seropositivity was not associated with increased CRC risk (OR = 0.91; 95% CI: 0.71-1.16). Among H. pylori seropositive subjects, seropositivity to Cag delta showed a lower CRC risk, and risk decreased with increasing number of proteins seropositive. Seropositivity to the most recognized virulence factors, CagA and VacA, was not associated with a higher CRC risk. No statistically significant heterogeneity was identified among tumor sites, although inverse relations were stronger for left colon cancer. An interaction with age and sex was found: H. pylori seropositivity was associated with a lower CRC risk in men younger than 65 and with a higher risk in older women.Conclusions: Our results suggest that neither H. pylori seropositivity, nor seropositivity to the virulence factor CagA are associated with a higher CRC risk. A possible effect modification by age and sex was identified.
Note: Reproducció del document publicat a:
It is part of: Frontiers in Microbiology, 2017, vol. 8
Related resource:
ISSN: 1664-302X
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (ISGlobal)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
675930.pdf1.69 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons